Glioma: all 1,425 studies
Page 1 of 15. Open to participants first (355), then studies with results posted, then the rest; newest registration first within each.
- IDH1-vac in Patients With Newly Diagnosed IDH1R132H-positive High-grade AstrocytomasNot yet recruitingNCT07888647Phase 2
- An Optimization Study Evaluating Safety and Efficacy of the Y-90 Glioblastoma (GBM) Device in Patients With Recurrent GBMNot yet recruitingNCT07867886Not applicable
- Metronomic Temozolomide With Dexbrompheniramine for Recurrent High-Grade Glioma/GlioblastomaNot yet recruitingNCT07859059Phase 1/2
- Metabolomics and Transcriptomics of Low- and High-Grade GliomasRecruitingNCT07832734
- Safusidenib for Patients With Newly Diagnosed IDH1-mutant CNS WHO Grade 3 Oligodendroglioma and Astrocytoma - a Single Arm Phase II StudyNot yet recruitingNCT07832123Phase 2
- A Study of SRN-101 Administered Prior to Surgical Resection in Adults With Recurrent High-Grade Glioma.Not yet recruitingNCT07826949Phase 1
- Phase II Elderly/Frail Pts With Newly Diagnosed or Recurrent Malignant Glioma Treated With Cesium-131 GammaTile®Not yet recruitingNCT07821112Phase 2
- A Preregistered Multi-Cohort Evaluation of the FATHOM AI System for Molecular Testing Prioritization to Support Clinical Trial EnrollmentNot yet recruitingNCT07814872
- Susceptibility-Weighted Imaging in Preoperative Grading of Cerebral GliomasNot yet recruitingNCT07813741
- Usefulness of Thromboelastography as a Predictor of Prognosis in Patients Undergoing Surgery for Glial Tumors and of the Risk of Postoperative Thromboembolic Disease (GliTEM)RecruitingNCT07813377
- FPS-ZM1 With or Without Dexamethasone for Controlling Post Operative Cerebral Edema in Patients With GlioblastomaNot yet recruitingNCT07791264Phase 1
- Tarlatamab Treatment Before and After Surgery in Surgically Resectable Recurrent High-grade Glioma: a Window of Opportunity Study (TARLAGLIA Study)Not yet recruitingNCT07788677Phase 1
- A Study of NST-628 in Recurrent Grade 4 GliomaNot yet recruitingNCT07784985Early Phase 1
- Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With CancerNot yet recruitingNCT07781852Early Phase 1
- Multiparametric Metabolic and Hypoxic PET/MRI Imaging Substudy in GliomasNot yet recruitingNCT07778979Early Phase 1
- STUPP Regimen With or Without Lenvatinib for Newly Diagnosed Glioblastoma With MGMT Promoter MethylationNot yet recruitingNCT07754734Phase 2
- Phase 1/2 Study Evaluating the Safety, PK/PD, and Clinical Activity of Oral JBI-778 in Patients With Brain Metastases, Leptomeningeal Disease, or Recurrent High Grade GliomaNot yet recruitingNCT07751744Phase 1/2
- Proton vs. Photon Radiotherapy for Patients With WHO Grade 2-3 GliomaRecruitingNCT07750457Not applicable
- Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)RecruitingNCT07733674Phase 1
- Characterization of the Blood-Brain Barrier in High-Grade Glioma Through Immunohistochemical, Transcriptional, Fluorescein and Radiological AnalysesRecruitingNCT07731555Not applicable
- Feasibility Assessment of a Medical Device for Tumour Cell Retention and Radiotherapy Sensitization in Patients With Suspected High-grade GliomaNot yet recruitingNCT07725640Not applicable
- Connectome-guided Onco-functional Resection With Tractography-Extended Neuronavigation in Brain Tumor SurgeryRecruitingNCT07717827
- A Clinical Trial Evaluating the Tolerability, Safety, and Preliminary Efficacy of NRG-103 Injection in Patients With Recurrent or Progressive High-grade GliomaRecruitingNCT07710690Phase 1
- Nimotuzumab Combined With the Stupp Regimen for Postoperative Residual GlioblastomaNot yet recruitingNCT07707973Phase 2
- AI-driven Processing and Analysis of Glioma Imaging DataRecruitingNCT07703761
- AI-Assisted MRI Molecular Subtyping in Pediatric Brain TumorsNot yet recruitingNCT07703605
- Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive DiseaseRecruitingNCT07703436Phase 2
- EEG-Guided Cognitive Function Preservation in Patients With Brain TumorsNot yet recruitingNCT07699172Not applicable
- Clinical Benefit of 18F-FET in Glioma.Not yet recruitingNCT07698457Phase 3
- A Study of HF1K16 Combined With Bevacizumab in Patients With Recurrent or Progressive GliomaRecruitingNCT07678684Phase 2
- Safety and Effectiveness Evaluation of Temozolomide (Amitzo, NanoAlvand) in Patients With Grade III and IV Glioma TumorsRecruitingNCT07675070
- NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain TumorsRecruitingNCT07664176Phase 1
- Movie-Watching Functional MRI for Mapping Brain Function in Neurosurgical PatientsNot yet recruitingNCT07650994Not applicable
- Study of Relatlimab and Nivolumab (Opdualag) in Replication Repair Deficient HGG and DIPGNot yet recruitingNCT07644312Phase 2
- Evaluation of [⁶⁸Ga/¹⁷⁷Lu]HT547: Safety, Biodistribution, and Dosimetry in Solid TumorsNot yet recruitingNCT07639970Early Phase 1
- Low-grade Gliomas in Argentina: Incidence, Survival, and Therapeutic StrategiesRecruitingNCT07631338
- VorAsidenib With Lomustine In Patients With rEcurrent IDH-mutaNT Glioma Harboring IDH1 and/or IDH2 MutationsNot yet recruitingNCT07629089Phase 1
- Living Well With Brain Cancer: A Group-Based Intervention to Promote Whole-Person Well-BeingNot yet recruitingNCT07628647Not applicable
- Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid TumorsRecruitingNCT07628634Early Phase 1
- Exploration and Characterization Ofintratumoral Electrophysiological Heterogeneity in Gliomas Using MagnetoencephalographyNot yet recruitingNCT07616726Not applicable
- Brain Connectivity Changes in Glioma Patients During TreatmentRecruitingNCT07612917
- FG001 Near-Infrared Fluorescence Imaging During Tumor Resection in Newly Diagnosed High-Grade GliomaNot yet recruitingNCT07609472Phase 2
- Multicenter Prospective Study on MRI AI Model for Midline Glioma Subtyping and Prognosis:RecruitingNCT07608003
- A Prospective, Single-arm Clinical Study on the Safety and Efficacy of Ivoximab Combined With Temozolomide in the Treatment of Relapsed/Refractory GliomaRecruitingNCT07599371Phase 1/2
- A Safety and Efficacy Study of Combined Fianlimab + Cemiplimab in Children and Young Adults With Recurrent or Progressive High-Grade Glioma or Posterior Fossa-A EpendymomaNot yet recruitingNCT07567469Phase 1/2
- PET-Guided Resection in High-Grade GliomasRecruitingNCT07567196
- Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade GliomaRecruitingNCT07551336Phase 1
- Patient Voice in the Treatment of Low-grade Gliomas: Use of Patient-reported Outcomes, Vorasidenib and Radiotherapy ComparedRecruitingNCT07547163
- Ultralow Dose PET Imaging of 18F-FDOPAEnrolling by invitationNCT07542158Phase 2
- Sitagliptin in Recurrent/Progressive Grade 4 GliomaRecruitingNCT07541781Phase 1
- A Study of Mirdametinib in People With Central Nervous System TumorsRecruitingNCT07539441Phase 1/2
- APT-weighted and Diffusion MRI for Characterizing Tumor Infiltration in High-Grade GliomasNot yet recruitingNCT07532031
- Efficacy of Mirdametinib Alone or Combination With Radiotherapy for Germline and Sporadic NF1-Altered High-Grade GliomaNot yet recruitingNCT07521657Phase 2
- Language Network Prehab Via fMRI NeurofeedbackRecruitingNCT07488780Not applicable
- Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) In Newly Diagnosed Glioma (WHO G3-G4)RecruitingNCT07488754Not applicable
- Olutasidenib DDI Study in Patients With IDH1 Mutation Positive MalignanciesRecruitingNCT07486713Phase 4
- IL13Rα2 CAR-T Cells Secreting Anti-PD-L1 Antibody for Recurrent Malignant GliomaNot yet recruitingNCT07481721Phase 1
- Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade GliomaRecruitingNCT07480941Phase 1
- A Study on the Novel Oncolytic Virus Combined With PD-1 Inhibitor in the Treatment of Recurrent High-grade GliomaNot yet recruitingNCT07472790Phase 1
- Neuromodulation-Induced Cortical Prehabilitation in High Grade Glioma Near the Motor Pathway: Cortical Plasticity Assessed by Navigated Transcranial Magnetic Stimulation (nTMS)Not yet recruitingNCT07471100Not applicable
- Vorasidenib Guided by AGX PET in Recurrent/Low-grade GliomaNot yet recruitingNCT07469735Not applicable
- Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade GliomasRecruitingNCT07468136Phase 1/2
- A First-in-Human Study of the CIPHER System During Brain Surgery for Newly Diagnosed GliomaRecruitingNCT07465796Not applicable
- A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade GliomaRecruitingNCT07464925Phase 1
- Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1RecruitingNCT07462507Phase 2
- Integrating Biology for Safe Intensification of Glioblastoma Hypofractionated Treatment on the MR-LinacNot yet recruitingNCT07457307Phase 1
- A Phase I Study of FZ-AD005 in Patients With High-Grade Glioma (HGG)Not yet recruitingNCT07455045Phase 1
- Symptom Cluster Heterogeneity and Gut Microbiota Mechanisms in Childhood Cancer SurvivorsRecruitingNCT07450872
- T2 Star Magnetic Resonance Imaging and Biomarker Blood Testing to Predict the Change and Progress of Malignant GliomasRecruitingNCT07447531Not applicable
- DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.RecruitingNCT07440290Phase 2/3
- Monitoring of Neurological Symptoms, Treatment Tolerance, and Quality of Life Using the Resilience PRO Electronic Patient-reported Outcome Application in Patients With IDH-mutated GliomaNot yet recruitingNCT07439302Not applicable
- Pre-Radiation Chemotherapy for Newly Diagnosed High-Grade Glioma.RecruitingNCT07439172Phase 2
- Fluorescence-Guided Imaging of Brain Tumors: A Safety Study Using SBK2-ICGNot yet recruitingNCT07438860Phase 1
- Intratumoral DNX-2401 for High Grade Pediatric Brain TumorsRecruitingNCT07424092Phase 2
- Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent GlioblastomaRecruitingNCT07416188Phase 1/2
- Comparison of Skin Closure Techniques in Oncological Neurosurgical Procedures: Intradermal Running Suture Versus Transdermal Interrupted SuturesRecruitingNCT07413796Not applicable
- Analysis of Cerebrospinal Fluid Leakage After Surgery for Intracranial TumorsRecruitingNCT07411690
- Construction and Application of an IDH Mutation-Targeted PET/MRI Imaging Framework for Precision Diagnosis of GliomasRecruitingNCT07405372
- Combination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG)Not yet recruitingNCT07389278Phase 1/2
- Amino Acid Transporter System PET/CT Imaging in AATS-Related DiseasesRecruitingNCT07379463
- Intraoperative Ultrasound for Brain Tumor Surgery Enhanced by AINot yet recruitingNCT07376304Phase 3
- Leica Microsystems Sponsored PMCF Study to Collect and Confirm Clinical Data on the Performance of the GLOW400 Device When Used in Accordance With Its Intended UseNot yet recruitingNCT07366892
- BIO-SHORT: Hypofractionated RT for Poor-Prognosis GBMRecruitingNCT07338539Not applicable
- Gallium Maltolate for the Treatment of Pediatric Patients With Relapsed or Refractory Pediatric High-Grade Glioma and Atypical Teratoid Rhabdoid TumorNot yet recruitingNCT07331064Phase 1
- Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIIIRecruitingNCT07326566Phase 2
- A Phase I Clinical Trial of a mRNA Vaccine for Recurrent or Progressive High-grade GliomaRecruitingNCT07306299Phase 1
- Evaluation of the Variation Over Time of Visuospatial Deficit in Patients With Parietal Lobe GliomaRecruitingNCT07286929
- Fluorescence Enhanced Stereotactic Surgery (FESS)RecruitingNCT07286903
- Prospective Real-World Study of Pathology AI for Glioma Molecular PredictionRecruitingNCT07263711
- Combination of Tarlatamab and Temozolomide in Patients With Central Nervous System TumorsRecruitingNCT07243470Phase 1/2
- A Phase I/IIa Study of C5252 in Patients With Intracranial TumorRecruitingNCT07243340Phase 1/2
- Vorasidenib in CNS WHO Grade 2 IDH-mutant Diffuse GliomaRecruitingNCT07240662
- Self-administered Remote Neurological Examination Using Mobile Application in Patients With Brain TumorsRecruitingNCT07236840
- A Study of 177Lu-PSMA-617 in People With GliomasRecruitingNCT07223034Phase 1
- Residual IDH1-Mutant Tumor Cell Quantification StudyNot yet recruitingNCT07219199Not applicable
- Phase I Trial of pH Resections of GBM at VANot yet recruitingNCT07218367Phase 1
- Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)RecruitingNCT07210632Early Phase 1
- Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG)Not yet recruitingNCT07206849Phase 2
- AI-assisted Diagnosis of Malignant Brain TumorsRecruitingNCT07198256
- Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoing Standard ChemotherapyRecruitingNCT07179328Phase 1